Week 9 2026

Dr. Park is an assistant professor in the department of Medical Oncology and Therapeutics Research and Population Sciences at City of Hope National Medical Center. Dr. Park graduated medical school from The College of Osteopathic Medicine of the Pacific at Western University of Health Sciences in Pomona, California. She completed her internal medicine residency program at Kaiser Permanente-Fontana. During her internal medicine training, she developed deep interest in genetics and pursued medical genetics training at University of California, Irvine. She is board certified in Internal Medicine and clinical genetics and genomics.

Joanne Jeter, MD, MS (she/her) is a board-certified medical oncologist and clinical cancer geneticist. She started working at City of Hope on October 16, 2023, and is very excited about joining many of her friends in this prestigious group. Her medical school training was at the University of Texas-Houston Health Sciences Center. She subsequently completed her residency in Internal Medicine at the University of Alabama-Birmingham. While she was in her Medical Oncology fellowship program at the University of Michigan, she was fortunate to start working with Dr. Stephen Gruber's clinical cancer genetics program, and this has been her primary focus since that time. She has also earned a Master's degree in Clinical Trials Design and Statistical Analysis at the University of Michigan. Prior to her time at City of Hope, she was the Medical Director for the Family Cancer Assessment Clinic at Huntsman Cancer Institute at the University of Utah. She has also worked as a medical oncologist and clinical cancer geneticist at the University of Arizona and the Ohio State University.

Dr. Bates is the Deputy Executive Director of the National Pharmacogenomics Program for the Department of Veterans Affairs, specializing in precision medicine. She is also Associate Professor of Clinical Education at the UNC Eshelman School of Pharmacy. Dr. Bates completed her Bachelor of Science at Eastern Illinois University, a Master of Science with concentration in biochemistry and biophysics at Northern Illinois University and her Doctor of Pharmacy at the University of Illinois at Chicago. She completed a post graduate year 1 (PGY1) pharmacy practice and PGY2 oncology pharmacy residency at Duke University Medical Center and is certified in both pharmacogenomics and precision oncology. Dr. Bates has experience as a leader in clinical pharmacy practice, oncology pharmacy, and residency training. She has a passion for advancing pharmacy practice through education rooted in the belief that learning improves lives. Dr. Bates was recognized for her achievements when she was selected as the inaugural recipient of the Milton W Skolaut leadership award bestowed by Duke University Medical Center, designated as Fellow by ASHP, and awarded the Distinguished Service Award in 2019 by the American Society of Health System Pharmacists Section of Clinical Specialists and Scientists.